A majority of experts on a panel advising the FDA voted to keep the controversial diabetes drug Avandia available for sale with tougher warnings. But a sizable minority called for withdrawing it.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/07/14/128519792/avandia-survives-as-experts-support-continued-sales-with-caveats?ft=1&f=103537970
Posted
Jul 14 2010, 01:54 PM
by
NPR Blogs: Shots - Health News Blog